Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 25% ± 12% | |
GABAergic neuron | 6 studies | 42% ± 17% | |
T follicular helper cell | 5 studies | 42% ± 17% | |
endothelial cell of artery | 5 studies | 28% ± 8% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 27% ± 13% | |
oligodendrocyte precursor cell | 4 studies | 32% ± 10% | |
interneuron | 4 studies | 25% ± 9% | |
T cell | 3 studies | 30% ± 15% | |
glutamatergic neuron | 3 studies | 38% ± 18% | |
group 3 innate lymphoid cell | 3 studies | 38% ± 12% | |
neuron | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 30% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 666.33 | 648 / 653 | 95% | 13.65 | 572 / 605 |
prostate | 99% | 1391.07 | 243 / 245 | 94% | 8.54 | 471 / 502 |
lung | 100% | 2836.53 | 578 / 578 | 89% | 8.27 | 1029 / 1155 |
esophagus | 97% | 2099.92 | 1398 / 1445 | 90% | 15.45 | 164 / 183 |
uterus | 90% | 531.64 | 153 / 170 | 78% | 10.72 | 359 / 459 |
bladder | 100% | 1541.05 | 21 / 21 | 68% | 6.43 | 341 / 504 |
stomach | 94% | 586.89 | 339 / 359 | 73% | 4.56 | 209 / 286 |
intestine | 89% | 582.05 | 862 / 966 | 73% | 4.71 | 387 / 527 |
brain | 73% | 703.49 | 1926 / 2642 | 87% | 10.62 | 612 / 705 |
adrenal gland | 67% | 246.09 | 174 / 258 | 79% | 8.48 | 181 / 230 |
breast | 88% | 523.40 | 406 / 459 | 56% | 2.97 | 629 / 1118 |
skin | 71% | 430.68 | 1287 / 1809 | 63% | 7.52 | 299 / 472 |
kidney | 69% | 269.72 | 61 / 89 | 65% | 6.94 | 590 / 901 |
ovary | 49% | 186.07 | 88 / 180 | 81% | 7.12 | 350 / 430 |
liver | 38% | 126.00 | 85 / 226 | 73% | 6.65 | 298 / 406 |
spleen | 94% | 429.97 | 227 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 59.16 | 27 / 29 |
adipose | 91% | 611.22 | 1100 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 9.86 | 41 / 45 |
pancreas | 2% | 4.93 | 7 / 328 | 86% | 5.81 | 153 / 178 |
blood vessel | 74% | 666.17 | 983 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 523.71 | 277 / 929 | 0% | 0 | 0 / 0 |
heart | 28% | 85.21 | 238 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 25% | 1.17 | 20 / 80 |
muscle | 6% | 22.26 | 47 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
Gene name | TOX2 |
Protein name | TOX high mobility group box family member 2 TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1) (GCX-1) |
Synonyms | GCX1 C20orf100 |
Description | FUNCTION: Putative transcriptional activator involved in the hypothalamo-pituitary-gonadal system. |
Accessions | Q96NM4 Q5JYD4 ENST00000341197.9 [Q96NM4-4] ENST00000413823.1 ENST00000423191.6 [Q96NM4-3] ENST00000372999.5 [Q96NM4-3] ENST00000358131.5 [Q96NM4-1] |